During the past decade, Regional Clinical Research (RCR) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Regional Clinical Research (RCR)" are "RNA Virus Infections" (2 trials), "Respiratory Tract Diseases" (2 trials), "Respiratory Tract Infections" (2 trials) and "Virus Diseases" (2 trials). Many other conditions were trialed in "Regional Clinical Research (RCR)" in a lesser frequency.

Most popular intervention types in "Regional Clinical Research (RCR)" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "30 µg/strain of Quadrivalent VLP Vaccine" (2 trials), "15 µg/strain of Quadrivalent VLP Vaccine" (1 trials), "15 µg/strain of the licensed quadrivalent vaccine" (1 trials), "60 µg/strain of Quadrivalent VLP Vaccine" (1 trials) and "FluLaval® Tetra (15 µg/strain)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional Clinical Research (RCR)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Regional Clinical Research (RCR)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Regional Clinical Research (RCR), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regional Clinical Research (RCR), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".